The study is to invesigate the effect of topiramate (TPM) on EEG by means of quantitative pharmacoelectroencephalography (QPEEG).
Methods:
One dose of TPM was administrated to epileptics and healthy adults. The EEG samples were obtained prior to and at regular intervals within the 24 hours following the administration of TPM. The EEG activity was processed with power spectral analysis.
Results:
The power of slow wave, alpha 1 bands and total power increased after the administration of TPM, the power or slow wave in both occipital areas, and the total power of all scalp areas also increased. The percent of power increased at the theta band and alpha 1 band (healthy adults) or delta band, theta band (patients).
Conclusion:
TPM can change the EEG background activity. These changes are different from other antiepileptic drugs.
HermannWMIrrgangU. An absolute must in clinico-pharmacological research; pharmacoelectroencephalography, its possibilities and limitations. Pharmacopsychiat1983; 16: 134–142.
2.
ItilTMKrynickiVE. Quantitative pharmaco-EEG in determining bioavailability and bioequivalency of psychotropic drugs. In: GapettERHirtzJL (eds). Drug Fate and Metabolism. New York, Basel: Marcel Dekker; 1983: 387–411.
3.
SannitaWGBalbiAGiacchinoFRosadiniG. Quantitative EEG effects and drug plasma concentraton of phenobarbital 50 and 100mg single-dose oral administration to healthy volunteers: Evidence of early CNS bioavailability. Neuropsychobiology1990–1991; 23: 205–212.
4.
WuXXiaoCH. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clin Electroencephalogr1993; 24: 93–99.
5.
WuXMaJJ. Sodium valproate: Quantitative EEG and serum levels in volunteers and epileptics. Clin Electroencephalogr1993; 24: 93–99.
6.
WuXXiaoCH. Quantitative pharmaco-EEG of sustained release valproate in epileptics. Clin Electroencephalogr1997; 28: 117–120.
7.
SannitaWGBalestraVDibonGHassanKMRosadiniG. Ammonia-independent modifications of the background EEG signal and paradoxical enhancement of epileptic abnormalities in EEG after acute administration of valproate to epileptic patients. Neuropharmacology1993; 32: 919–928.
8.
WuXLiuXQ. Study of the alpha frequency band of healthy adults in quantitative EEG. Clin Electroencephalogr1995; 26: 131–136.
9.
WuX. Antiepilepsy drugs. In: JiaBQLuYL (eds). Modern Clinical Practical Drugs Handbook. 2nd ed.Peking Medical University; 2001: 230 (in Chinese).
10.
ShankRPGardockiJFStreeterAJMaryanoffBE. An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action. Epilepsia2000; 41(suppl 1): S3–S9.
11.
Patsalos. The pharmacokinetic profile of topiramate. Rev Contemp Pharmacother1999; 10: 155–162.
LindbergerMTomsonTÖhmanIWallstedtLStåhleL. Estimation of topiramate in subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma: A single case of microdialysis study. Epilepsia1999; 40: 800–802.
14.
HerkesGKLagerlundTDSharbroughFWEadieM. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol1993; 10: 210–216.
15.
SaletuBGrunbergerJ, Linzmazer. Evaluation of encephaloptropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int J Clin Pharmacol Ther Toxicol1986; 24: 362–373.
16.
MattiaDSpaneddaFBassettiMARomigiAPlacidiFMarcianiMG. Gabapentin as add-on in focal epilepsy: A computerized EEG study. Clin Neurophysiology2000; 111: 311–317.
17.
MarcianiaMGStanzionePMaschioM. EEG changes induced by vigabatrin monotherapy in focal epilepsy. Acta Neurol Scand1997; 95: 115–120.
18.
EbertUThongNQOertelRKirchW. Effects of rifampicin and cimetidine on pharmacokinetics of lamotrigine in healthy subjects. Eur J Clin Pharmacol2000; 56: 299–304.
19.
Van WieringenABinnieCDMeijerJWAPeckAWDeVriesJ. Comparison of the effects of lamotrigine and phenytoin on the EEG power spectrum and cortical and brainstem-evolved responses of normal human volunteers. Neuropsychobiology1989; 21: 157–169.
20.
NeufeldMYKoganEChistikVKorczynAD. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Clin Neuropharmacol1999; 22: 80–86.
